Výsledky vyhledávání

Akademický článek

Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study.

Autor: Beypınar İ; Department of Medical Oncology, Alanaya Alaaddin Keykubat University, Alanya, Turkey. ibeypinar@yahoo.com., Demir H; Department of Medical Oncology, Afyonkarahisar Health Sciences University, Afyon, Turkey., Yaslıkaya Ş; Department of Medical Oncology, Çukurova University, Adana, Turkey., Köşeci T; Department of Medical Oncology, Çukurova University, Adana, Turkey., Demir B; Department of Medical Oncology, Aydın Adnan Menderes University, Aydın, Turkey., Çolak G; Department of Medical Oncology, Aydın Adnan Menderes University, Aydın, Turkey., Ağaoğlu AB; Department of Medical Oncology, Celal Bayar University, Manisa, Turkey., Şahbazlar M; Department of Medical Oncology, Celal Bayar University, Manisa, Turkey., Şancı PC; Department of Medical Oncology, Kocaeli University, Kocaeli, Turkey., Çabuk D; Department of Medical Oncology, Kocaeli University, Kocaeli, Turkey., Işık U; Department of Medical Oncology, Kocaeli City Hospital, Kocaeli, Turkey., Şahin E; Department of Medical Oncology, Kocaeli City Hospital, Kocaeli, Turkey., Coşkun A; Department of Medical Oncology, Uludağ University, Bursa, Turkey., Caner B; Department of Medical Oncology, Uludağ University, Bursa, Turkey., Aykut T; Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey., Artaç M; Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey., Duygulu ME; Department of Medical Oncology, Karadeniz Technical University, Trabzon, Turkey., Sever N; Department of Medical Oncology, Marmara University, Istanbul, Turkey., Öksüz S; Department of Medical Oncology, Kartal Lütfü Kırdar Research and Education Hospital, Istanbul, Turkey., Turan N; Department of Medical Oncology, Kartal Lütfü Kırdar Research and Education Hospital, Istanbul, Turkey., Aykan MB; Department of Medical Oncology, Gülhane Research and Education Hospital, Ankara, Turkey., Tüzün EK; Department of Medical Oncology, Gülhane Research and Education Hospital, Ankara, Turkey., Uysal M; Department of Medical Oncology, Vocational School of Health Services, Medstar Antalya Hospital, Antalya Bilim University, Antalya, Turkey., Uğurlu İ; Department of Medical Oncology, Sakarya Research and Education Hospital, Sakarya, Turkey., Sakin A; Department of Medical Oncology, Medipol University, Istanbul, Turkey., Acar C; Department of Medical Oncology, Ege University, İzmir, Turkey., Özaşkın D; Department of Medical Oncology, Afyonkarahisar Health Sciences University, Afyon, Turkey., Şakalar T; Department of Medical Oncology, Kahramanmaraş Necip Fazıl City Hospital, Kahramanmaraş, Turkey., Keskinkılıç M; Department of Medical Oncology, Dokuz Eylül University, İzmir, Turkey., Yavuzşen T; Department of Medical Oncology, Dokuz Eylül University, İzmir, Turkey., Köse N; Department of Medical Oncology, Memorial Hospital, Ankara, Turkey., Ertürk İ; Department of Medical Oncology, Gülhane Research and Education Hospital, Ankara, Turkey., Yıldırım N; Department of Medical Oncology, Fırat University, Elazığ, Turkey., Balçık OY; Department of Medical Oncology, Alanaya Alaaddin Keykubat University, Alanya, Turkey., Alkan A; Department of Medical Oncology, Muğla Sıtkı Koçman University, Muğla, Turkey., Selvi O; Department of Medical Oncology, Prof.Dr Cemil Taşçıoğlu City Hospital, Istanbul, Turkey., Erçin E; Department of Medical Oncology, Ümraniye Research and Education Hospital, Istanbul, Turkey., Ünal OÜ; Department of Medical Oncology, Tepecik Research and Education Hospital, İzmir, Turkey., Karaçin C; Department of Medical Oncology, Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey.

Publikováno v: Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Dec; Vol. 208 (3), pp. 597-604. Date of Electronic Publication: 2024 Aug 09.

Zobrazit plný text záznamu

Akademický článek

Efficacy of adjuvant capecitabine in residual triple negative breast cancer: a multicenter observational Turkish Oncology Group (TOG) study.

Autor: Taşçı EŞ; Department of Medical Oncology, Kanuni Sultan Süleyman Education and Research Hospital, Istanbul, Turkey., Kutlu Y; Department of Medical Oncology, Medipol University, Istanbul, Turkey., Ölmez ÖF; Department of Medical Oncology, Medipol University, Istanbul, Turkey., Mutlu AU; Department of Medicine, Acıbadem MAA University, Istanbul, Turkey., Gündoğdu Y; Department of Internal Medicine, Acıbadem MAA University, Istanbul, Turkey., Seyyar M; Department of Medical Oncology, Kocaeli University, Kocaeli, Turkey., Şahin E; Department of Medical Oncology, Kocaeli University, Kocaeli, Turkey., Çabuk D; Department of Medical Oncology, Kocaeli University, Kocaeli, Turkey., Majidova N; Department of Medical Oncology, Marmara University Faculty of Medicine, Istanbul, Turkey., Uğurlu İ; Department of Medical Oncology, Sakarya University Research and Education Hospital, Sakarya, Turkey., Demirci A; Department of Medical Oncology, Sakarya University Research and Education Hospital, Sakarya, Turkey., Aydın D; Department of Medical Oncology, Derince Education and Research Hospital, Kocaeli, Turkey., Çavdar E; Department of Medical Oncology, Namık Kemal University, Tekirdağ, Turkey., Bayram S; Department of Medical Oncology, Antalya Education and Research Hospital, Antalya, Turkey., Yıldırım N; Department of Medical Oncology, Fırat University Faculty of Medicine, Elazığ, Turkey., Karataş F; Department of Medical Oncology, Karabük University Faculty of Medicine, Karabük, Turkey., Eryılmaz MK; Meram Faculty of Medicine, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey., Çağlayan D; Meram Faculty of Medicine, Department of Medical Oncology, Necmettin Erbakan University, Konya, Turkey., Menekşe S; Department of Medical Oncology, Manisa City Hospital, Manisa, Turkey., Kut E; Department of Medical Oncology, Manisa City Hospital, Manisa, Turkey., Arak H; Department of Medical Oncology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey., Keser M; Department of Medical Oncology, Tepecik Training and Research Hospital, Istanbul, Turkey., Sunar V; Department of Medical Oncology, Aydın Atatürk Public Hospital, Aydın, Turkey., Perkin P; Department of Medical Oncology, Ankara City Hospital, Ankara, Turkey., Şakalar T; Department of Medical Oncology, Necip Fazıl City Hospital, Kahramanmaraş, Turkey., Oyan B; Department of Medical Oncology, Acıbadem MAA University, Istanbul, Turkey., Sönmez Ö; Department of Medical Oncology, Acıbadem MAA University, Istanbul, Turkey., Özer L; Department of Medical Oncology, Acıbadem MAA University, Istanbul, Turkey., Yıldız İ; Department of Medical Oncology, Acıbadem MAA University, Istanbul, Turkey.

Publikováno v: Expert opinion on pharmacotherapy [Expert Opin Pharmacother] 2024 Mar; Vol. 25 (4), pp. 477-484. Date of Electronic Publication: 2024 Apr 03.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání